Risk of herpes zoster according to past history in the general population: The Japanese Shozu herpes zoster study.
cross-sectional study
erythema diameter
follow-up study
herpes zoster
past history
Journal
The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
revised:
03
04
2023
received:
14
02
2023
accepted:
29
04
2023
medline:
5
9
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
ppublish
Résumé
Immunity is known to persist after vaccination for varicella zoster virus, but the duration of immunity in patients who develop herpes zoster (HZ) remains unknown. To investigate the association between a past history of HZ and its occurrence in the general population. The Shozu HZ (SHEZ) cohort study included data for 12 299 individuals aged ≥50 years with information on their HZ history. Cross-sectional and 3-year follow-up studies were carried out to analyze the associations between a history of HZ (yes <10 years, yes ≥10 years, no) and the proportion of positive varicella zoster virus skin test results (erythema diameter ≥5 mm) and the risk of HZ after adjusting for potential confounding factors including age, sex, body mass index, smoking status, sleep duration, and mental stress. The incidences of positive skin test results were 87.7% (470/536) for individuals with a history of HZ <10 years ago, 82.2% (396/482) for those with a history of HZ ≥10 years, and 80.2% (3614/4509) for those with no history of HZ. The multivariable odds ratios (95% confidence intervals) of erythema diameter ≥5 mm were 2.07 (1.57-2.73) and 1. 39 (1.08-1.80) for individuals with a history <10 years and ≥10 years ago, respectively, compared with no history. The corresponding multivariable hazard ratios of HZ were 0.54 (0.34-0.85) and 1.16 (0.83-1.61), respectively. A past history of HZ <10 years ago may reduce the occurrence of HZ.
Identifiants
pubmed: 37334747
doi: 10.1111/1346-8138.16828
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1140-1144Informations de copyright
© 2023 Japanese Dermatological Association.
Références
Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9:361-81.
Bansal R. Recurrent herpes zoster. Int J Dermatol. 2001;40:542-3.
Burke BL, Steele RW, Beard OW, Wood JS, Cain TD, Marmer DJ. Immune responses to varicella-zoster in the aged. Arch Intern Med. 1982;142:291-3.
Burkhart CN. Recurrent herpes zoster revisited. Int J Dermatol. 2002;41:528.
Horiuchi Y. Recurrent herpes zoster. J Dermatol. 1998;25:347-8.
Schwarz TF, Volpe S, Catteau G, Chlibek R, David MP, Richardus JH, et al. Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults. Hum Vaccin Immunother. 2018;14:1370-7.
Vukmanovic-Stejic M, Sandhu D, Seidel JA, Patel N, Sobande YO, Agius E, et al. The characterization of varicella zoster virus-specific T cells in skin and blood during aging. J Invest Dermatol. 2015;135:1752-62.
Shiraki K, Toyama N, Daikoku T, Yajima M. Herpes zoster and recurrent herpes zoster. Open Forum Infect Dis. 2017;4:ofx007.
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-84.
Oxman MN, Levin MJ, Shingles Prevention Study Group. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197(Suppl 2):S228-36.
Morrison VA, Johnson GR, Schmader KE, Levin MJ, Zhang JH, Looney DJ, et al. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis. 2015;60:900-9.
Takao Y, Miyazaki Y, Onishi F, Kumihashi H, Gomi Y, Ishikawa T, et al. The Shozu herpes zoster (SHEZ) study: rationale, design, and description of a prospective cohort study. J Epidemiol. 2012;22:167-74.
Schmader KE, Oxman MN, Levin MJ, Johnson G, Zhang JH, Betts R, et al. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis. 2012;55:1320-8.
Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, et al. Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: the SHEZ study. J Epidemiol. 2015;25:617-25.
Okuno Y, Takao Y, Miyazaki Y, Ohnishi F, Okeda M, Yano S, et al. Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster. Epidemiol Infect. 2013;141:706-13.
Ban J, Takao Y, Okuno Y, Mori Y, Asada H, Yamanishi K, et al. Association of cigarette smoking with a past history and incidence of herpes zoster in the general Japanese population: the SHEZ study. Epidemiol Infect. 2017;145:1270-5.
Kawahira K, Imano H, Yamada K, Takao Y, Mori Y, Asada H, et al. Risk of herpes zoster in relation to body mass index among residents aged ≥50 years: the Shozu herpes zoster study. J Epidemiol. 2022;32:370-5.
Takao Y, Okuno Y, Mori Y, Asada H, Yamanishi K, Iso H. Associations of perceived mental stress, sense of purpose in life, and negative life events with the risk of incident herpes zoster and postherpetic neuralgia: the SHEZ study. Am J Epidemiol. 2018;187:251-9.
Yamada Y, Kubota Y, Shimizu Y, Cui R, Mori Y, Okuno Y, et al. Sleep shortage is associated with postherpetic neuralgia development through hyperesthesia and acute pain intensity: a community-based prospective cohort study. Pain Pract. 2019;19:476-83.
Takahashi M, Okada S, Miyagawa H, Amo K, Yoshikawa K, Asada H, et al. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine. 2003;21:3845-53.